Search
for
Sort by
Research 541–570 of 1000+
- Cutaneous Drug Delivery: An Update
- Niosomes as a propitious carrier for topical drug delivery
- Niosomes as Carrier in Dermal Drug Delivery
- Errata
- Multiple minute digitate hyperkeratosis
- Diseases of the skin. Drug ill effects on the skin.
- Drug-induced changes in hair growth
- Penetration of drugs through skin, a complex rate-controlling membrane
- Penetration and storage of particles in human skin: Perspectives and safety aspects
- Alopecia areata-successful outcome with microneedling and triamcinolone acetonide
- Evaluation of Oral Minoxidil in the Treatment of Alopecia Areata
- Nanoemulgels: A new approach for the treatment of skin-related disorders
- A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
- The Effect of Particle Size on the Deposition of Solid Lipid Nanoparticles in Different Skin Layers: A Histological Study
- 5α-Reductase inhibitors in androgenetic alopecia
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris
- Topical imiquimod—Be aware of the unexpected
- Minoxidil and bilateral central serous chorioretinopathy in an adolescent girl: relationship or causality?
- Urticariform plaques: delayed hypersensitivity reaction type IV to enoxaparin
- The Siblings with Blistered Legs: Marking Nut Maladies in India
- Presence of Psoriasis in Areas of Balding in Patients with Both Androgenic Alopecia and Scalp Psoriasis
- Antiulcer drugs
- Anthracycline analogs The past, present, and future
- The pharmacology of methotrexate
- Hair Growth Cycle Affects Hair Follicle Destruction by Ruby Laser Pulses
- Hormonal Therapy for Acne
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology